43
Publications
3.4K
Citations
32
H-Index
2012
Active since
Dongwen Lv is an author at Capital Normal University specializing in medicine, natural sciences, and proteomics.
Top concepts
MedicineNatural SciencesProteomicsPlant PhysiologyBiologyGeneticsBiochemistryBotanyGene ExpressionMolecular Biology
Publications per year
2012–2025
43
43
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 608 citations · Full text
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
Dongwen Lv, Pratik Pal, Xingui Liu et al. · Nature Communications · 2021 · 140 citations · Full text
Rows per page
1–5 of 43